With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, ...

Vamil Divan, Guggenheim Securities analyst, joins 'Squawk on the Street' to discuss Pfizer's guidance, how optimistic Divan ...

Michael Morris, Guggenheim Securities analyst, joins 'Squawk on the Street' to discuss what's at stake for Netflix, some of ...

First Stamford Place is the new home of Guggenheim Partners' Connecticut office. Photo courtesy of Newmark Group STAMFORD – The ...

The Guggenheim's Orphism exhibition includes more than 90 artworks on display in its iconic rotunda, celebrating the 1910s ...

As previously reported, Guggenheim initiated coverage of Neogen (NEOG) with a Buy rating and $15 price target Neogen is a ...

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution ...

This is what sign language poetry, a genre rooted in the sign language tradition, looks like: a feast for the eyes.

“Harmony & Dissonance” at the Guggenheim Museum is a mood-lifting, masterpiece-studded show that offers an in-depth look at Orphism, which is famous for being unknown. Frantisek ...

Historical fiction on the famed bohemian collector brings her relationships to life but leaves out much of what she actually ...

Guggenheim lowered the firm’s price target on Pfizer (PFE) to $33 from $35 and keeps a Buy rating on the shares. Pfizer will be releasing their ...

Guggenheim lowered the firm’s price target on AnaptysBio (ANAB) to $36 from $90 and keeps a Buy rating on the shares following the announcement ...